Sanctuary Advisors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,472
Closed -$45K 2362
2025
Q1
$45K Sell
2,472
-60
-2% -$1.71K ﹤0.01% 2149
2024
Q4
$77.3K Sell
2,532
-26
-1% -$995 ﹤0.01% 2334
2024
Q3
$101K Buy
+2,558
New +$142K ﹤0.01% 2312

Other funds holding CDLX

Sanctuary Advisors's CDLX Position: Q2 2025 in Review

Sanctuary Advisors sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 2,472 shares — an estimated $45K sold.

Sanctuary Advisors first reported a position in CDLX in Q3 2024 and held it in 3 quarters. The position peaked at $101K in Q3 2024. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Sanctuary Advisors reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Sanctuary Advisors sold 2,472 Cardlytics shares in Q2 2025, an estimated $45K.
  • Sanctuary Advisors first reported a position in Cardlytics in Q3 2024 and held it in 3 quarters.
  • Sanctuary Advisors's Cardlytics position peaked at $101K in Q3 2024.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Sanctuary Advisors's 13F filing for Q2 2025, filed 6 Jan 2026.